In this trial, we are evaluating the safety and tolerability of a needle-free investigational DNA vaccine to protect against SARS CoV-2 virus. As you are aware, this virus has caused an outbreak of an illness called coronavirus disease-19 (called COVID-19) around the world. In this study, it is the first time that this particular vaccine is given to humans.
You are required to come into the clinic 10 times in total. The duration of your participation in the study is approximately 12 months.
To be eligible you can not have had a COVID-19 vaccine and must be:
A healthy male or healthy female who is not pregnant